BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
37.12
+0.02 (0.04%)
Aug 24, 2026, 11:37 AM EDT - Market open
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 106.69 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 | |
Revenue Growth | 30.12% | 28.89% | 9.75% | -10.79% | -36.02% | 147.79% |
Cost of Revenue | 38.82 | 34.1 | 24.55 | 26.7 | 29.33 | 80.98 |
Gross Profit | 67.87 | 62.12 | 50.1 | 41.32 | 46.91 | 38.18 |
Selling, General & Admin | 55.98 | 55.37 | 49.56 | 54.17 | 44.93 | 47.67 |
Research & Development | 9.77 | 7.57 | 4.75 | 5.52 | 8.67 | 11.82 |
Amortization of Goodwill & Intangibles | 0.37 | 0.26 | 0.26 | 1.03 | 3.99 | 8.2 |
Operating Expenses | 66.12 | 63.2 | 54.57 | 60.72 | 57.59 | 67.7 |
Operating Income | 1.75 | -1.08 | -4.48 | -19.4 | -10.68 | -29.52 |
Interest Expense | - | - | -0.77 | -1.41 | -0.28 | -0.49 |
Interest & Investment Income | 3.38 | 2.71 | - | - | - | - |
Other Non Operating Income (Expenses) | 1.82 | 1.82 | 0.49 | 1.28 | 0.66 | 0.17 |
EBT Excluding Unusual Items | 6.94 | 3.44 | -4.75 | -19.53 | -10.3 | -29.84 |
Merger & Restructuring Charges | - | - | - | - | - | -2.77 |
Gain (Loss) on Sale of Investments | -0.11 | - | -4.07 | - | 0.7 | - |
Other Unusual Items | - | - | - | 7.31 | 4.75 | 3.58 |
Pretax Income | 6.83 | -12.08 | -8.82 | -12.22 | -4.85 | -29.03 |
Income Tax Expense | -42.38 | 0.05 | -0.04 | -0.06 | -5.24 | -20.12 |
Earnings From Continuing Operations | 49.21 | -12.13 | -8.79 | -12.16 | 0.39 | -8.91 |
Earnings From Discontinued Operations | 8.77 | 7.54 | -11.4 | -55.85 | -140.19 | - |
Net Income to Company | 57.98 | -4.6 | -20.18 | -68 | -139.81 | -8.91 |
Net Income | 57.98 | -4.6 | -20.18 | -68 | -139.81 | -8.91 |
Net Income to Common | 57.98 | -4.6 | -20.18 | -68 | -139.81 | -8.91 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 48 | 46 | 44 | 42 | 39 |
Shares Outstanding (Diluted) | 50 | 49 | 46 | 44 | 43 | 39 |
Shares Change | 5.54% | 5.60% | 5.37% | 1.50% | 11.87% | 41.01% |
EPS (Basic) | 1.20 | -0.10 | -0.44 | -1.56 | -3.29 | -0.23 |
EPS (Diluted) | 1.16 | -0.10 | -0.44 | -1.56 | -3.29 | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 7.63 | 9.75 | 3.14 | -23.74 | -22.41 | -19.35 |
Free Cash Flow Per Share | 0.15 | 0.20 | 0.07 | -0.54 | -0.52 | -0.50 |
Gross Margin | 63.61% | 64.56% | 67.11% | 60.75% | 61.53% | 32.04% |
Operating Margin | 1.64% | -1.12% | -6.00% | -28.52% | -14.01% | -24.77% |
Profit Margin | 54.35% | -4.78% | -27.04% | -99.98% | -183.38% | -7.48% |
Free Cash Flow Margin | 7.16% | 10.13% | 4.20% | -34.90% | -29.39% | -16.24% |
EBITDA | 6.9 | 3.61 | 4.18 | -7.1 | -3.1 | -16.65 |
EBITDA Margin | 6.47% | 3.75% | 5.61% | -10.44% | -4.06% | -13.98% |
D&A For EBITDA | 5.15 | 4.69 | 8.66 | 12.3 | 7.58 | 12.87 |
EBIT | 1.75 | -1.08 | -4.48 | -19.4 | -10.68 | -29.52 |
EBIT Margin | 1.64% | -1.12% | -6.00% | -28.52% | -14.01% | -24.77% |
Revenue as Reported | - | - | - | - | 76.24 | 119.16 |
Advertising Expenses | - | 0.4 | 0.9 | 0.8 | 0.4 | 0.6 |